Literature DB >> 18488231

[Visual acuity after cataract surgery in patients with age-related macular degeneration].

H Baatz1, R Darawsha, G Scharioth, D De Ortueta, H Ackermann.   

Abstract

BACKGROUND: To analyze changes in visual acuity after cataract surgery in patients suffering from age-related maculopathy.
MATERIAL AND METHODS: This retrospective case-control study included all patients who had consecutively undergone phacoemulsification from January 2000 to February 2006, had a preexisting diagnosis of early age-related macular degeneration (AMD), and were followed up for at least 1 year postoperatively (n=1,152 eyes of 696 patients). The control group comprised phakic patients diagnosed with early AMD from January 2000 to February 2006 who did not undergo eye surgery and were followed up for at least 1 year (n=334 eyes of 202 patients).
RESULTS: In 62.1% of operated eyes, the best-corrected visual acuity was at least two logMAR units better than before surgery, and in 26.7% it was at least four logMAR units better. Deterioration of visual acuity of more than four logMAR units occurred in 1.3% of operated eyes and 1.5% of control eyes.
CONCLUSION: Cataract surgery can markedly improve visual acuity in patients with age-related maculopathy.

Entities:  

Mesh:

Year:  2008        PMID: 18488231     DOI: 10.1007/s00347-008-1760-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  19 in total

1.  The standard gamble between cataract extraction and AMD.

Authors:  Paulus T V M de Jong; Jacobus Lubsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

2.  Cataract surgery in patients with age-related macular degeneration: one-year outcomes.

Authors:  Ana Maria Armbrecht; Catherine Findlay; Peter Alan Aspinall; Adrian Robert Hill; Baljean Dhillon
Journal:  J Cataract Refract Surg       Date:  2003-04       Impact factor: 3.351

3.  Combined Phaco-Emulsification Cataract Extraction and Pars plana Vitrectomy without Intra-Ocular Lens Implantation.

Authors:  T L Jackson; J Larsson; V Tanner; T H Williamson
Journal:  Ophthalmologica       Date:  2001 Jul-Aug       Impact factor: 3.250

4.  The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara E K Klein; Tien Y Wong; Sandra C Tomany; Karen J Cruickshanks
Journal:  Arch Ophthalmol       Date:  2002-11

Review 5.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

6.  Cataract surgery in patients with age-related maculopathy: preoperative diagnosis and postoperative visual acuity.

Authors:  Thuan Q Pham; Jie J Wang; Anthony Maloof; Paul Mitchell
Journal:  Clin Exp Ophthalmol       Date:  2005-08       Impact factor: 4.207

7.  [Does cataract surgery increase the risk of exudative age-related macular degeneration? Results from a large retrospective case-control study].

Authors:  M Menghini; F K Sutter; D Barthelmes; J C Fleischhauer; M M Kurz-Levin; M M Boesch; H Helbig
Journal:  Klin Monbl Augenheilkd       Date:  2007-04       Impact factor: 0.700

8.  Cataract surgery and quality of life in patients with age related macular degeneration.

Authors:  M Lundström; K G Brege; I Florén; B Lundh; U Stenevi; W Thorburn
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  Phacoemulsification does not induce neovascular age-related macular degeneration.

Authors:  Holger Baatz; Raed Darawsha; Hanns Ackermann; Gábor B Scharioth; Diego de Ortueta; Mitrofanis Pavlidis; Lars O Hattenbach
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

10.  Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies.

Authors:  Jie Jin Wang; Ronald Klein; Wayne Smith; Barbara E K Klein; Sandy Tomany; Paul Mitchell
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.